Revalor® S

A growth promotant with slow release of active principle which induces the increased laying down of lean meat without increasing fat deposition.

REVALOR®-S

Reg. No. G2024 (Act 36/1947)

INDICATIONS

For cattle

Revalor®-S is a growth promotant with slow release of trenbolone acetate and oestradiol which induces the increased laying down of lean meat without increasing fat deposition. There is an improvement in mass gain and feed conversion. The active principles have short half-lives on release into the plasma obviating carcass residue problems.

COMPOSITION

Each implant contains: 140 mg of trenbolone acetate and 28 mg β-oestradiol.

STORAGE

  • Store unopened product at or below 25 °C.
  • Avoid excessive heat and humidity.
  • Use product before the expiry date.

WARNINGS

  • DO NOT USE IN ANIMALS INTENDED FOR BREEDING PURPOSES.
  • ONLY FOR USE IN BULLS, STEERS AND HEIFERS IN FEEDLOTS.
  • Handle with care. Harmful if swallowed.
  • Implant pellets behind ear only. Do not use implant site for human or animal consumption.
  • Store away from food and feed.
  • Dispose of any containers, disposable equipment and any other waste after use, in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008) and do not reuse for any other purpose.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

A cartridge consists of 10 implants each containing 7 small tablets. A single implant is placed under the skin by means of a special implanter (Refer to implanter instructions).

Site of implantation

After appropriately restraining the animal to allow access to the ear, cleanse the skin at the implant needle puncture site.

The site of implantation is the soft skin on the posterior aspect of the ear.

The implant should be placed as far from the head as possible without inserting the implanter into the area where the skin is firmly attached to the cartilage.

THE IMPLANT MUST NOT BE PLACED CLOSER TO THE HEAD THAN THE EDGE OF THE CARTILAGE RING FARTHEST FROM THE HEAD.

The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site.

Care should be taken to avoid injuring the major blood vessels or cartilage of the ear.

Fig. 1 – Ear of bovine ready for implantation
Fig. 2 – Rear view of the bovine ear showing the site for insertion of the implanter needle

PRESENTATION

Contains 20 doses in 2 cartridges with 10 implants per cartridge.

Contains 100 doses in 10 cartridges with 10 implants per cartridge.

Contains 500 doses in 50 cartridges with 10 implants per cartridge.

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF PACKAGE INSERT 2 March 2007